Related Experiment Videos
Diurnal 18-hydroxy-11-deoxycorticosterone pattern in human stable hypertension
The Journal of Clinical Endocrinology and Metabolism
|October 1, 1978
Summary
Diurnal 18-hydroxy-11-deoxycorticosterone (18-OH-DOC) levels were studied in hypertensive patients. The study found 18-OH-DOC does not appear to be a major factor in essential hypertension.
Area of Science:
- Endocrinology
- Hypertension Research
- Steroid Hormone Analysis
Background:
- Understanding the diurnal patterns of steroid hormones is crucial for diagnosing endocrine disorders.
- 18-hydroxy-11-deoxycorticosterone (18-OH-DOC) is a mineralocorticoid precursor with potential relevance in hypertension.
- Radioimmunoassay (RIA) is a standard technique for quantifying steroid hormones in biological samples.
Observation:
- Diurnal 18-OH-DOC patterns were assessed in 33 hypertensive patients using RIA every 2 hours.
- Plasma aldosterone and cortisol levels were measured concurrently.
- Abnormal 18-OH-DOC patterns were noted in 2 of 4 Cushing's disease patients and sporadically in 5 of 24 essential hypertensive patients.
Findings:
- Elevated 18-OH-DOC levels were observed infrequently in essential hypertension, sometimes correlating with cortisol (F) levels.
- 18-OH-DOC levels were normal in patients with hypertension secondary to renal artery stenosis, nephrosclerosis, and horseshoe kidney.
- The study suggests 18-OH-DOC has limited pathogenetic role in stable essential hypertension due to its low mineralocorticoid activity.
Implications:
- These findings suggest that 18-OH-DOC is unlikely to be a primary driver in the development of essential hypertension.
- Further research may explore the specific roles of other mineralocorticoids in hypertensive conditions.
- Accurate diurnal hormone profiling remains vital for differentiating hypertensive etiologies.